about
Differentiation of mesenchymal stem cells derived from pancreatic islets and bone marrow into islet-like cell phenotypePlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardiumAnalysis of different medulloblastoma histotypes by two-dimensional gel and MALDI-TOF.Host fibrinogen stably bound to hemozoin rapidly activates monocytes via TLR-4 and CD11b/CD18-integrin: a new paradigm of hemozoin action.Hemozoin induces hepatic inflammation in mice and is differentially associated with liver pathology depending on the Plasmodium strain.Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues.Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation.Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment.Nutraceuticals and "repurposed" drugs of phytochemical origin in prevention and interception of chronic degenerative disease and cancer.Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways.Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?A multi-cellular 3D bioprinting approach for vascularized heart tissue engineering based on HUVECs and iPSC-derived cardiomyocytesDownregulation of Pro-Inflammatory and Pro-Angiogenic Pathways in Prostate Cancer Cells by a Polyphenol-Rich Extract from Olive Mill WastewaterPro-Inflammatory Cytokine Genes Influence the Clinical Features of Frontotemporal Lobar DegenerationMyeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor ProgressionAcetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategiesNatural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects
P50
Q28741267-67854D85-42C5-4047-98FA-59F8F2A11F00Q30573513-209C4DEC-DF9F-4C4A-8C30-571E13F6CFEFQ33946693-F8B40667-43BA-4ED6-9779-69759C5708ABQ34175387-C1A48714-6286-4CDF-AA42-69A50DB1EE5BQ34566112-0F3846D1-4631-47E8-9AB7-6711AB1B26A9Q38650903-62D4954E-85D6-430E-BC73-B01B62042B27Q48162963-F5684D22-F1E0-4C35-B91F-CA92B853BC84Q49346065-FB36767B-9958-4289-9675-AF8613EED7E6Q49967747-EDB8C9A4-46A9-4DF7-8ED2-824C951F87A9Q52573700-D47A13B2-F5DD-4966-B215-A05585D074C5Q52672848-32E763C8-A8DB-4BB4-9BCF-786B373D0726Q58756008-BAECECF7-E591-4F7F-8E21-A6C5BC5F0650Q61818124-85045D5F-6E6E-4F82-BE50-ED664A881E0AQ62381890-9B84944C-E875-4B1C-ACB1-FCCF47C60447Q64102304-D694E10A-EA29-4982-8211-C0418711C460Q91257540-EB6A382B-FB73-40D8-9619-8620F8B8D422Q92794916-4DCC2BD9-4C80-45FC-91D6-F77D67F503F3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Denisa Baci
@ast
Denisa Baci
@en
Denisa Baci
@es
Denisa Baci
@nl
Denisa Baci
@sl
type
label
Denisa Baci
@ast
Denisa Baci
@en
Denisa Baci
@es
Denisa Baci
@nl
Denisa Baci
@sl
prefLabel
Denisa Baci
@ast
Denisa Baci
@en
Denisa Baci
@es
Denisa Baci
@nl
Denisa Baci
@sl
P106
P1153
26653449400
P31
P496
0000-0001-6474-0970